Skip to main content

estradiol

Generic: ESTRADIOL·Brand: ALORA, Alora, Bijuva, CLIMARA, Climara, Climara Pro, Combipatch, Compudose, DELESTROGEN, DIVIGEL, Delestrogen, Depo-estradiol, Divigel, Dotti, ELESTRIN, ESCLIM, ESTRACE, ESTRADERM, ESTRADIOL, ESTRADIOL VALERATE, ESTRING, ESTROGEL, EVAMIST, Elestrin, Estrace, Estring, Estrogel, Evamist, FEMPATCH, FEMRING, FEMTRACE, Femring, GYNODIOL, IMVEXXY, INNOFEM, Imvexxy, Lyllana, MENOSTAR, MINIVELLE, Menostar, Minivelle, Myfembree, Revalor, Synovex, Synovex C, Synovex H, Synovex S, VAGIFEM, VIVELLE, VIVELLE-DOT, Vagifem, Vivelle, Yuvafem

estradiol: developed by 1 company · 2 clinical trials tracked · 1 FDA decision.

estradiol evidence translation

What we can confirm

1 FDA record · 2 tracked trials

What it means

Source-backed records connect estradiol to VTRS; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could estradiol → VTRS affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 2 study sponsors

Related indications

No linked indication is available.

Development Pipeline (1)
CompanyPhase
Viatris Inc (VTRS)Approved
Clinical Trials (2)

Copenhagen Menopause Study (COMPASS): A Randomized Clinical Trial

NCT07254429·Phase 2·CDTX
Recruiting

Primary endpoint: Change in bone remodeling from baseline to week 8.

InterventionalRandomizedsingle192 targetStarted 2025-10Completion 2028-051 site · DenmarkMartin Blomberg Jensen

Comparison of Vaginal Estradiol and Oral Guaifenesin Interventions in Patients Undergoing Ovulation Induction With Clomiphene Citrate

NCT07398924·N/A·ENTA
Completed

Primary endpoint: Clinical pregnancy rate

InterventionalRandomizedsingle90 enrolledStarted 2022-01Completion 2023-061 site · Turkey (Türkiye)Yuzuncu Yil University
FDA Decisions1 records
Approval1 INDICATIONS AND USAGE ELESTRIN is an estrogen indicated for the treatment of moderate to severe vasomotor symptoms due to menopause ( 1.1 ) 1.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause(VTRS)FDA ↗
NDA021813Type 5 - New Formulation or New ManufacturerStandardOtherGel, Metered

Frequently asked questions

Who is developing estradiol?

estradiol is being developed by Viatris Inc.

How many clinical trials involve estradiol?

BioSniper tracks 2 clinical trials involving estradiol.

What is estradiol's latest FDA decision?

The most recent tracked FDA decision for estradiol is Approval for 1 INDICATIONS AND USAGE ELESTRIN is an estrogen indicated for the treatment of moderate to severe vasomotor symptoms due to menopause ( 1.1 ) 1.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause, dated December 15, 2006.